Chargement en cours...
Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching.
Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial. However, the mechanisms underlying the effica...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science (PLoS)
2012-01-01
|
| Collection: | PLoS ONE |
| Accès en ligne: | http://europepmc.org/articles/PMC3471825?pdf=render |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|